Skip to content

Cognitive Control of Language

Cognitive Control of Language and Frontal Cortex

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03124173
Acronym
LANGUAGE
Enrollment
23
Registered
2017-04-21
Start date
2015-01-14
Completion date
2016-05-19
Last updated
2025-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

fMRI, cingulate cortex, adaptation, frontal cortex

Brief summary

The cognitive control of speech is central to human social communication. Two frontal brain regions seem to have a critical role: 1) Broca's area (BA) and 2) the mid-cingulate cortex (MCC). Current rehabilitation strategy is clearly based on therapies promoting language performance. However, there is few evidence that rehabilitation strategies based on nonlinguistic aspects of brain function may enhance recovery. Such strategies may benefit from knowledge about the primary -nonlinguistic- function of the BA-MCC network. The aim of LANGUAGE is to identify this primary function. One hypothesis is that, in non-speaking primates, this network is involved in cognitive control of voluntary vocal/orofacial production. Specifically, whereas BA may be responsible for the high-level selection of orofacial and vocal responses during learning, the face motor representation within the MCC may be responsible for performance monitoring, a process inherently required in learning. LANGUAGE aims to test this hypothesis by determining in human the anatomo-functional organization of the BA-MCC network thanks to functional magnetic resonance imaging (fMRI).

Interventions

The subjects will be trained to realize several versions of a learning task of conditional visuo-motor associations.

OTHERFirst fMRI session

In this session (involving a condition specific to man and a condition that we are certain to obtain in the monkey), subjects will have to learn by trial and error during successive trials, the conditional associations between three abstract stimuli and three Manual responses (3 MRI-compatible mouse buttons).

In this session (involving a condition specific to man and a condition that we are almost certain to obtain in monkeys), subjects will have to learn by trial and error during successive trials, the conditional associations between three abstract stimuli and Three orofacial responses (3 movements of the mouth).

OTHERThird session of fMRI

In this session (involving a human-specific condition and a condition we hope to achieve in the monkey), subjects will have to learn by trial-error in successive trials, conditional associations between three abstract stimuli and three verbal or Vocals.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* being able to provide a written consent form * having a social insurance * have a normal vision (with or without corrections) * Right-handed

Exclusion criteria

* Subjects with MRI contraindications (e.g. pacemaker, claustrophobia, metal in the body, etc…). * Subjects must be willing to be advise in case of discovery of brain abnormality. * History of known neurological or psychiatric illness * Pregnant or nursing women * Persons under guardianship, curators or any other administrative or judicial measure of deprivation of rights

Design outcomes

Primary

MeasureTime frameDescription
Behavioral data: performance in the task3 yearsPerformance in the task will be assessed. If performance in the task is \<80%, subjects will be excluded in the final analysis
fMRI data3 yearsBOLD signal will be analyzed in relation to the events of the task. Images must be not too much distorted to allow data analysis. As such, if a subject moved too much (translation\>10mm; rotation\>5°) the corresponding data will be excluded from the analysis.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026